Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Comment by Investandprayon Jun 23, 2010 7:08pm
338 Views
Post# 17216221

RE: RE: RE: RE: RE: follow up news is not good

RE: RE: RE: RE: RE: follow up news is not good
  Very good points Waserwisk. Why does the FDA seem so clueless here?? Didn't they get 1 million pieces of paper with data when Lux filed and this still is not enough? How they worded their message made it sound like they are dealing with amateurs. Keep in mind Lux is also at fault here not just ISA. Lux conducted all the trials for this application. Lux is mostly to blame here IMO. Something smells really bad here. ISA just can't do anything right. Cash is almost out and now no indication as to when to expect the next review. Like most investors I have bailed out and will look at buying in at 5 cent range. I have been a ISA shareholder for 8 years so I am very fed up with this BS. GLTA  
<< Previous
Bullboard Posts
Next >>